Login
$CRDF
$0.88 +$0.07 (8.8%) Close

Insider Transactions

What Cardiff Oncology, Inc.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.

Insider trades

3 months 12 months
Open-market buys 0 4
Sells 0 0
Total trades 0 4

Shares traded

3 months 12 months
Acquired 0 776,352
Disposed 0 0
Net activity +0 +776,352

See the story behind these numbers

View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.

Open-market buyer Disclosed 10b5-1 Heavy discretionary Sign up free

All transactions

Insider Relation Date Transaction Shares Price Value Shares held
Mohindru Mani Chief Executive Officer Jul 14 Open-market buy · P +34,364 $1.46 +$50K 59,067
Pace Gary W Director Jul 14 Open-market buy · P +687,285 $1.46 +$1M 2,043,661
Pace Gary W Director Jun 18 Open-market buy · P +30,000 $1.22 +$36.6K 1,356,376
Mohindru Mani Chief Executive Officer Jun 18 Open-market buy · P +24,703 $1.21 +$29.9K 24,703
Pace Gary W Director Jul 30 Open-market buy · P +15,000 $2.45 +$36.8K 1,345,676
Pace Gary W Director Jul 30 Open-market buy · P +275,000 $2.45 +$674K 1,330,676
Levine James E. Chief Financial Officer Dec 18 Open-market buy · P +2,400 $5.00 +$12K 67,716
Levine James E. Chief Financial Officer Dec 17 Open-market buy · P +2,752 $5.42 +$14.9K 65,316
Levine James E. Chief Financial Officer Dec 16 Open-market buy · P +2,564 $3.83 +$9.82K 62,564
Tannenbaum Renee P Director Dec 12 Open-market buy · P +10,000 $3.42 +$34.2K 20,000
Pace Gary W Director Dec 11 Open-market buy · P +11,500 $2.60 +$29.9K 1,059,376
Pace Gary W Director Dec 11 Open-market buy · P +350,115 $2.60 +$910K 1,047,876
Pace Gary W Director Dec 19 Open-market buy · P +30,000 $1.37 +$41.1K 697,761
Pace Gary W Director Nov 10 Open-market buy · P +22,950 $0.98 +$22.5K 667,761
Erlander Mark Chief Executive Officer Nov 25 Open-market buy · P +10,000 $1.43 +$14.3K 24,481
White Lale Director Sep 19 Open-market buy · P +15,000 $1.64 +$24.5K 113,788
Levine James E. Chief Financial Officer Sep 16 Open-market buy · P +30,000 $1.56 +$46.7K 60,000
Armitage James O Director Sep 16 Open-market buy · P +13,000 $1.56 +$20.2K 13,000
Tannenbaum Renee P Director Sep 15 Open-market buy · P +3,600 $1.72 +$6.19K 10,000
Tannenbaum Renee P Director Sep 15 Open-market buy · P +6,400 $1.72 +$11K 6,400

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support